FIELD: medicine.
SUBSTANCE: there is offered mode that involves penetrant delivery of getting substances through coat of an animal and provides formation of at least one delivery way in skin tissue of the average depth within approximately 40 to approximately 90 micron.
EFFECT: measured depth of the way and average depth of the way does not depend on the type of micropore formation system applied.
83 cl, 4 ex, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TRANSDERMAL DELIVERY OF PERMEANT SUBSTANCES | 2014 |
|
RU2691310C2 |
| METHOD FOR PERCUTANEOUS PENETRANT DELIVERY | 2004 |
|
RU2531923C2 |
| METHOD FOR FORMING MICRO-PORES IN HUMAN SKIN FOR DELIVERING MEDICAMENTS AND CARRYING OUT MONITIRING | 1996 |
|
RU2209031C2 |
| COMPOSITION CONTAINING LIPID NANOPARTICLES AND CORTICOSTEROID OR VITAMIN D DERIVATIVE | 2012 |
|
RU2602171C2 |
| IMPROVING ABSORPTION OF THERAPEUTIC AGENTS THROUGH MUCOUS MEMBRANES OR SKIN | 2009 |
|
RU2519193C2 |
| METHODS AND COMPOSITIONS FOR LIGHT DELIVERY OF INSULIN | 1995 |
|
RU2175556C2 |
| METHOD OF SAMPLING SUBCUTANEOUS INTERSTITIAL FLUID BY MEANS OF MICRONEEDLE APPLICATOR | 2014 |
|
RU2567826C1 |
| CELL-PENETRATING PEPTIDES | 2010 |
|
RU2548807C2 |
| SYSTEMS AND METHODS FOR LASER SURGICAL AND THERAPEUTIC EYE TREATMENTS | 2018 |
|
RU2766775C2 |
| TRANSPORTING FILLER, WHICH CONTAINS ONE OR MORE DI- AND/OR MONO-(ELECTRONIC TRANSMITTING AGENT) PHOSPHATE DERIVATIVES OR THEIR COMPOUNDS | 2006 |
|
RU2434643C2 |
